| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 10 | +30.00% | -2.25% | +0.29% | -2.54% | -4.69% | — |
| 14d | 10 | +50.00% | +4.40% | +1.56% | +2.84% | -0.69% | — |
| 30d | 10 | +90.00% | +9.77% | +1.47% | +8.30% | -1.55% | — |
| 60d | 10 | +60.00% | +1.83% | +5.90% | -4.07% | -10.77% | — |
| 90d | 10 | +50.00% | +4.30% | +7.32% | -3.02% | -9.29% | — |
| 180d | 10 | +50.00% | +19.61% | +14.07% | +3.94% | -14.80% | — |
| 1y | 10(1 pending) | +66.67% | +42.73% | +28.71% | +14.02% | +11.10% | — |
| 2y | 10(3 pending) | +85.71% | +75.43% | +45.02% | +30.41% | -5.12% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CCCC C4 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 62,000 | — | — | 62,000 | Jun 24, 2026 | Jun 26, 2026 ↗ | View → |
| ANAB ANAPTYSBIO, INC | PURCHASEGRANT Stock grant | 11,250 | — | — | 11,250 | May 11, 2026 | May 13, 2026 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Chief Executive Officer | 10,568 | — | — | 191,264 | Apr 20, 2026 | Apr 22, 2026 ↗ | View → |
| XOMA XOMA ROYALTY CORP | SALE Chief Executive Officer | 10,568 | — | — | 116,245 | Apr 20, 2026 | Apr 22, 2026 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASEGRANT Stock grant | 82,428 | — | — | 180,696 | Mar 16, 2026 | Mar 17, 2026 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASEGRANT Stock grant | 126,813 | — | — | 126,813 | Mar 16, 2026 | Mar 17, 2026 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Chief Executive Officer | 100,000 | $25.05 | $2.50M | 102,000 | Dec 4, 2025 | Dec 8, 2025 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Chief Executive Officer | 35,567 | — | — | 98,268 | Sep 19, 2025 | Sep 23, 2025 ↗ | View → |
| XOMA XOMA ROYALTY CORP | SALE Chief Executive Officer | 35,567 | — | — | 132,714 | Sep 19, 2025 | Sep 23, 2025 ↗ | View → |
| CCCC C4 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,500 | — | — | 35,500 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| XOMA XOMA ROYALTY CORP | SALE Chief Executive Officer | 25,637 | $25.38 | $650.7K | 62,701 | May 20, 2025 | May 21, 2025 ↗ | View → |
| XOMA XOMA ROYALTY CORP | SALE Chief Executive Officer | 53,359 | — | — | 168,281 | May 19, 2025 | May 21, 2025 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Chief Executive Officer | 53,359 | — | — | 88,338 | May 19, 2025 | May 21, 2025 ↗ | View → |
| XOMA XOMA ROYALTY CORP | SALE Chief Executive Officer | 21,881 | $29.95 | $655.3K | 34,979 | Nov 13, 2024 | Nov 13, 2024 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Chief Executive Officer | 53,360 | — | — | 56,860 | Nov 11, 2024 | Nov 13, 2024 ↗ | View → |
| XOMA XOMA ROYALTY CORP | SALE Chief Executive Officer | 53,360 | — | — | 221,640 | Nov 11, 2024 | Nov 13, 2024 ↗ | View → |
| CCCC C4 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 32,500 | — | — | 32,500 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASEGRANT Stock grant | 275,000 | — | — | 275,000 | Jan 8, 2024 | Jan 10, 2024 ↗ | View → |
| CCCC C4 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 52,000 | — | — | 52,000 | Nov 16, 2023 | Nov 20, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Exec Chairman and Interim CEO | 1,000 | $13.83 | $13.8K | 3,500 | Oct 2, 2023 | Oct 4, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Exec Chairman and Interim CEO | 2,499 | $14.43 | $36.1K | 2,500 | Sep 26, 2023 | Sep 27, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Exec Chairman and Interim CEO | 1 | $14.65 | $15 | 1 | Sep 25, 2023 | Sep 27, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Interim CEO | 1,032 | $23.79 | $24.6K | 2,000 | May 24, 2023 | May 25, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Interim CEO | 768 | $23.49 | $18.0K | 968 | May 23, 2023 | May 25, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASE Interim CEO | 200 | $23.33 | $4.7K | 200 | May 23, 2023 | May 25, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| XOMA XOMA ROYALTY CORP | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASE President and CEO | 2,500 | $21.00 | $52.5K | 506,226 | Jan 12, 2021 | Jan 14, 2021 ↗ | View → |
| CGEM CULLINAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 433,332 | — | — | 433,332 | Jan 7, 2021 | Jan 7, 2020 ↗ | View → |